pharmaceuticals

Sector Showcase: Biotech stocks are the "transformer" Michael Bay should be watching

Matt Weller
June 23, 2017
The world's largest biotech fund, the iShares Nasdaq Biotech ETF, has had a quiet couple of months. For the last four months, the fund has been consolidating in a tight range between about 285.00 and 303.00. That changed abruptly this week, with prices surging out of that range to hit a high above 320.00.

Pharma's middlemen will feel the squeeze in 2017

Robert Cyran, Reuters
December 30, 2016
The pharmaceutical industry's middlemen face a 2017 clampdown.

The election and the Fed Funds (video)

Daniel P. Collins
November 17, 2016
Dan Collins, Editor in Chief, Modern Trader magazine, discusses how the election results will not change the anticipated rate hike in December.

Ackman defends Valeant

Svea Herbst-Bayliss, Reuters
October 30, 2015
Hedge fund mogul William Ackman told his investors on Friday that he was confident in his bet on Valeant Pharmaceuticals.

S&P surge slowed

Inyoung Hwang
February 4, 2015
Due to geopolitics, equities are becoming more volatile, causing U.S. stock index futures to fall after a major rally.